Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

Here are five new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists: Methotrexate injection: Assertio Specialty ...

Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ADX-2191 ...

Alan J. Franklin, MD, PhD, FASRS, presented, "Postoperative methotrexate injections decrease reoperation rate and improve vision following vitrectomy for PDR and complex retinal detachments," at the ...

LEXINGTON, Mass.--(BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and Drug ...

ADX-2191 is an investigational methotrexate injection for primary vitreoretinal lymphoma, a rare cancer with no FDA-approved treatments. The FDA requires a single clinical trial, alongside literature ...